Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review

• Váldodahkkit: Qiang Tong (Dahkki), Peng-chong Zhu (Dahkki), Zhuang Zhuang (Dahkki), Li-hui Deng (Dahkki), Zi-hao Wang (Dahkki), Hua Zeng (Dahkki), Guo-qing Zheng (Dahkki), Yan Wang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Notoginsenoside R1 (NGR1) exerts pharmacological actions for a variety of diseases such as myocardial infarction, ischemic stroke, acute renal injury, and intestinal injury. Here, we conducted a preclinical systematic review of NGR1 for ischemia reperfusion (I/R) injury. Eight databases were searche...